Hemp Studies Underway at Colorado State University’s College of Agricultural Sciences with Charlotte’s Web’s CW Labs
DENVER–(TSX: CWEB) (OTCQX: CWBHF) Supporting sound scientific data is a priority for the market leader in full spectrum hemp extract wellness products, Charlotte’s Web Holdings, Inc. The Company’s CW Labs science division and Colorado State University’s College of Agricultural Sciences have completed the first of three collaborative metabolomic hemp studies researching the complex chemical profile of full spectrum hemp extracts made from the Company’s U.S. patented hemp cultivars. The collaboration examines cannabinoid profiles in hemp extracts under varying cultivars and conditions.
Specifically, the studies explore the degree at which environmental conditions, geographic regions, harvesting times and different extraction methods may affect the resulting phytochemical profile of the hemp plant and the subsequent botanical extracts. Phase I of the investigation explicitly analyzed how hemp harvest processing and extraction protocols can be standardized for consistent chemical profile.
Under the oversight of Dr. Jessica Prenni, Associate Professor in the Department of Horticulture at CSU, graduate student Janina Bowen researched the Company’s proprietary hemp extracts in the Prenni Lab of the College of Agricultural Sciences.
“This is one of more than a dozen third-party scientific investigations Charlotte’s Web is conducting on the efficacy and safety of our hemp extracts. We have a commitment to advancing the science on hemp to support personal health and well-being through these collaborative investigations. We’re honored to work with Dr. Prenni and the team at Colorado State University,” Charlotte’s Web CEO Deanie Elsner said.
In phase I, the team at CSU has been collaborating with Charlotte’s Web’s CW Labs research scientists to examine hemp extracts for phytocannabinoids, terpenes, and various other compounds using sophisticated analytical equipment including liquid chromatography (LC-) and gas chromatography (GC-) coupled to mass spectrometry (MS) and more.
“We are thrilled to have the opportunity to work with Charlotte’s Web and contribute to building the knowledge base around full spectrum hemp extract products,” CSU’s Dr. Prenni said.
Long term, the study data discovered as a result this academic research will provide a deeper understanding of the range of constituents in full spectrum hemp extract, and an understanding of what factors can affect that profile. The information is intended to guide optimizing phytochemical fingerprints and will help to improve agricultural and extraction methods, and further standardize the process, procedures, test methods and controls for consistency and reproducibility.
Phase I of this scientific collaboration has been underway for more than two years and the research will be formally peer reviewed and published.
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Charlotte’s Web to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.
Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including assumptions as to the efficacy and results of research; and the adverse impact of the COVID-19 pandemic to the Company’s operations. These foregoing lists are not exhaustive. Additional information on these and other factors which could affect the Company’s operations or financial results are included in the Company’s most recent annual information form and other public documents on file with the Canadian Securities regulatory authorities on www.sedar.com.
Innocan Pharma Reports Significant Revenue Growth and Impressive Gross Profit in Q1 2023
LOS ANGELES-- Innocan Pharma Corporation, a pharmaceutical technology company specializing in innovative drug delivery platform technologies, has announced its financial results for the first quarter ended March 31, 2023. The company reported significant growth in ...
Minnesota Legalizes Adult-Use or Recreational Cannabis
ST PAUL, MN–Minnesota Governor Tim Walz, a Democrat, made a significant move on Tuesday by signing a bill that legalizes the recreational use of cannabis in the state. With this signature, Minnesota becomes the 23rd ...
Canopy Growth Acquires 19.99% Stake in Indiva, Secures Distribution Rights for Wana Edibles in Canada
LOS ANGELES-- In a strategic move to expand its presence in the cannabis edibles market, Canadian cannabis producer Canopy Growth has announced the acquisition of a 19.99% stake in edibles manufacturer Indiva. The deal also ...